Anaplastic Lymphoma Kinase (ALK) regulates initiation of transcription of MYCN in neuroblastoma cells
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anaplastic Lymphoma Kinase (ALK) regulates initiation of transcription of MYCN in neuroblastoma cells
Authors
Keywords
-
Journal
ONCOGENE
Volume 31, Issue 50, Pages 5193-5200
Publisher
Springer Nature
Online
2012-01-30
DOI
10.1038/onc.2012.12
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Addiction of MYCN amplified tumours to B-MYB underscores a reciprocal regulatory loop
- (2015) Oncotarget
- Evaluation of EML4-ALK Fusion Proteins in Non–Small Cell Lung Cancer Using Small Molecule Inhibitors
- (2015) Yongjun Li et al. NEOPLASIA
- Activating ALK mutations found in neuroblastoma are inhibited by Crizotinib and NVP-TAE684
- (2011) Christina Schönherr et al. BIOCHEMICAL JOURNAL
- Anaplastic lymphoma kinase expression in neuroblastomas and its relationship with genetic, prognostic, and predictive factors
- (2011) Arnaud Berthier et al. HUMAN PATHOLOGY
- Appearance of the Novel Activating F1174S ALK Mutation in Neuroblastoma Correlates with Aggressive Tumor Progression and Unresponsiveness to Therapy
- (2010) T. Martinsson et al. CANCER RESEARCH
- Meta-analysis of Neuroblastomas Reveals a Skewed ALK Mutation Spectrum in Tumors with MYCN Amplification
- (2010) S. De Brouwer et al. CLINICAL CANCER RESEARCH
- Protein kinase signaling networks in cancer
- (2010) John Brognard et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Crizotinib — Latest Champion in the Cancer Wars?
- (2010) Bengt Hallberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Crizotinib inALK-Rearranged Inflammatory Myofibroblastic Tumor
- (2010) James E. Butrynski et al. NEW ENGLAND JOURNAL OF MEDICINE
- EML4-ALK Mutations in Lung Cancer That Confer Resistance to ALK Inhibitors
- (2010) Young Lim Choi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
- (2010) Eunice L. Kwak et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anaplastic lymphoma kinase activates the small GTPase Rap1 via the Rap1-specific GEF C3G in both neuroblastoma and PC12 cells
- (2010) C Schönherr et al. ONCOGENE
- Myc proteins as therapeutic targets
- (2010) W C Gustafson et al. ONCOGENE
- Anaplastic lymphoma kinase: signalling in development and disease
- (2009) Ruth H. Palmer et al. BIOCHEMICAL JOURNAL
- Stabilization of N-Myc Is a Critical Function of Aurora A in Human Neuroblastoma
- (2009) Tobias Otto et al. CANCER CELL
- The Axin1 scaffold protein promotes formation of a degradation complex for c-Myc
- (2009) Hugh K Arnold et al. EMBO JOURNAL
- Overall Genomic Pattern Is a Predictor of Outcome in Neuroblastoma
- (2009) Isabelle Janoueix-Lerosey et al. JOURNAL OF CLINICAL ONCOLOGY
- High incidence of DNA mutations and gene amplifications of theALKgene in advanced sporadic neuroblastoma tumours
- (2008) Helena Carén et al. BIOCHEMICAL JOURNAL
- Identification of ALK as a major familial neuroblastoma predisposition gene
- (2008) Yaël P. Mossé et al. NATURE
- Activating mutations in ALK provide a therapeutic target in neuroblastoma
- (2008) Rani E. George et al. NATURE
- Oncogenic mutations of ALK kinase in neuroblastoma
- (2008) Yuyan Chen et al. NATURE
- Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma
- (2008) Isabelle Janoueix-Lerosey et al. NATURE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now